Competitive Acquisition Program Christian G. Downs, JD, MHA Executive Director Association of Community Cancer Centers.

Slides:



Advertisements
Similar presentations
Optima Medicare (PPO) Plans CY Medicare Medicare is a Federal health insurance program for those age 65 or older or individuals at any age who have.
Advertisements

Taking a Deeper Dive: Regulatory Issues You Should Really Understand -- Reimbursement and Payment Update Presented by Joseph W. Metro June 6, 2004.
Medicare, Health Reform, and You. Dont Worry! The benefits that Medicare guarantees will not change.
THE COMMONWEALTH FUND Affordable Care Act of 2010: Major Provisions and Implementation Timeline Sara R. Collins, Ph.D. Vice President, Affordable Health.
TABLE OF CONTENTS CHAPTER 1.0: Trends in the Overall Health Care Market Chart 1.1: Total National Health Expenditures, 1980 – 2010 Chart 1.2: Percent.
1 THE COMMONWEALTH FUND Source: The Commonwealth Fund Health Care Opinion Leaders Survey, July Assessment of Medicare Part D Now that the first-ever.
Figure 1. CMS Estimates of Eligibility and Participation in the Medicare Part D Low-Income Subsidy Full/partial dual eligibles and SSI recipients automatically.
INTEGRITY ● ACCESS ● VALUE 1 The 340B Drug Pricing Program: The Basics Paul Shank Health & Human Services Consultant, Health Resources and Services Administration.
National Health Expenditure Projections, 2012–22: Slow Growth until Coverage Expands and Economy Improves Gigi A. Cuckler, Andrea M. Sisko, Sean P. Keehan,
AAMC Contacts: Ivy Baer, J.D., M.P.H. Sr. Director and Regulatory Counsel Evan Collins, M.H.A. Specialist, Clinical Operations and Policy.
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015.
1 Controlling Costs in Medicare Jack Hoadley Research Professor Georgetown University Health Policy Institute Citizens’ Health Care Working Group Public.
1 CMS ePrescribing Activities Countdown to MMA: New & Unfinished Business Maria A. Friedman, DBA Senior Advisor Office of eHealth Standards and Services.
AREA AGENCY ON AGING AND DISABILITY STATE HEALTH INSURANCE ASSISTANCE PROGRAM (SHIP) 2012 Medicare 101.
Self-Select Voluntary Separation Program (SSVSP) 1.
TAYLOR MELANSON Providing Prescription Drug Coverage to the Elderly: America’s Experiment with Medicare Part D By Mark Duggan, Patrick Healy, and Fiona.
Medicare Part D Overview of Options, Creditable Coverage, Required Notices, COB and Health Care Reform.
Part D Data Sharing Harry Gamble Office of Financial Management CMS.
National Health Expenditure Projections, 2014–24: Spending Growth Faster Than Recent Trends Sean P. Keehan, Gigi A. Cuckler, Andrea M. Sisko, Andrew J.
Prescription Drug Improvement and Modernization Act Dorothy Della Sherwood, M.D. Presbyterian Hospital of Dallas 2/22/2006.
Risë Marie Cleland President, Oplinc Evaluating CAP Participation ANCO 2005 Annual Meeting Yosemite.
1 State Perspectives on Medicare Part D: Lessons from Pharmacy Plus Programs Cindy Parks Thomas Donald Shepard Christine E. Bishop Daniel M. Gilden Brandeis.
Medicare’s Disease Management Activities Stuart Guterman Director, Office of Research, Development, and Information Centers for Medicare & Medicaid Services.
Improving Cultural Competency Among Medical Professionals Kansas Public Health Association, Inc Fall Conference.
Healthcare Challenges - Current CMS Initiatives Steve McAdoo Deputy Regional Administrator, Dallas Centers for Medicare & Medicaid Services
Blue Cross of Idaho Medicare Advantage Provider Fraud, Waste and Abuse Training Fall 2009.
Slide -1 Medicare Prescription Drug Benefit Denise S. Stanley, Pharm.D. Atlanta Regional Office Centers for Medicare & Medicaid Services March 17, 2006.
Medicare Advantage Overview Diane Rowland, Sc.D. Executive Vice President Kaiser Family Foundation Alliance for Health Reform July 16, 2007.
MMA Implementation: Employer Response to the MMA The Second National Medicare Prescription Drug Congress Mark Hamelburg, Director Employer Policy & Operations.
Coverage of Cessation Services for Medicare Beneficiaries: An “Almost” Success Story Linda A. Bailey Executive Director, NAQC Smoking Cessation Leadership.
1 Variation in Medicare Part D Prescription Drug Plan Benefits, 2006 Leslie M. Greenwald, Ph.D. Principal Scientist RTI, International.
© 2009 Cengage Learning. All Rights Reserved. Medicare.
Chart 1.1: Total National Health Expenditures, 1980 – 2011 (1) Source: Centers for Medicare & Medicaid Services, Office of the Actuary. Data released.
Chartbook 2005 Trends in the Overall Health Care Market Chapter 1: Trends in the Overall Health Care Market.
Slide 1 Drug Pricing Considerations Medicare Prescription Drug, Improvement, and Modernization Act of 2003 ___________ Copyright 2005 Arnold & Porter July.
Stretching Program Dollars: Creative Solutions in Cost Containment Presentation to aaa+ ADAP Crisis Summit July 6, 2010.
CENTERS for MEDICARE & MEDICAID SERVICES Tom Scully CMS Administrator.
1 Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) VICAP Fall Training October 23, 2008 Kathy Nguyen CMS Health Insurance Specialist.
Draft Model Manufacturer Agreement Medicare Coverage Gap Discount Program Public Meeting June 1, 2010.
6.05 New Opportunities for Drugs under Old Medicare: Changes to Inpatient New Technology Pass-Throughs and ‘Incident to’ Coverage February 27, 2004 Christopher.
Ian D. Spatz Merck & Co., Inc. January 14, 2004 Ian D. Spatz Merck & Co., Inc. January 14, 2004 Overview of the New Medicare Prescription Drug Law.
Financing Administration of 2009 H1N1 Influenza Vaccine Megan C. Lindley, MPH National Center for Immunization and Respiratory Diseases July 27, 2009.
1 Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Title III – Combating Waste, Fraud, and Abuse Janet Rehnquist, Esq. Venable LLP.
The Future of Medicare Advantage The Heritage Foundation September 10, 2008 James C. Capretta Fellow, Ethics and Public Policy Center
Figure 1. Enrollment in Medicare Managed Care Plans as a Percentage of Total Medicare Beneficiaries, 1995–2008 BBA 1997MMA 2003 Source: Centers for Medicare.
Conroy & Associates, Inc. Medicare Overview Contact Bill Conroy | Medicare Became Law in 1965 Medicare.
Medicare Part B CAP Dead ?… GTCbio September 10, 2007.
Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Deirdre Duzor Director, Pharmacy Division Centers for Medicare & Medicaid Services.
The National Health Expenditure Accounts Team
Beth Faiman MSN, APRN-BC, AOCN Cleveland Clinic Taussic Cancer Institute Pre-Doctoral Research Fellow Case Western Reserve University Cleveland, Ohio America’s.
Medical Coding & Insurance Unit 8 Seminar. CMS Centers for Medicare and Medicaid Services (CMS) Centers for Medicare and Medicaid Services (CMS) Purpose:
Chart 1.1: Total National Health Expenditures, 1980 – 2013 (1) Source: Centers for Medicare & Medicaid Services, Office of the Actuary. Data released.
Slide 1 The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) An Update Grant P. Bagley, MD, JD
Estimating the Cost of the Medicare Drug Benefit Philip Ellis Steve Lieberman Medicare Prescription Drug Congress February 27, 2004.
MEDICARE PART D July MEDICARE PART D: OVERVIEW Part D provides prescription drug coverage for Medicare beneficiaries. Prescription drug plans compete.
Enforcement Trends in the Pharmaceutical Industry Lewis Morris Chief Counsel Office of Inspector General, DHHS.
Overview of the Medicare Drug Benefit Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy Project The Henry J. Kaiser Family.
MEDICARE PART B DRUG PAYMENT PROPOSAL Proposed CMS Rule Cuts Reimbursement For Physician- Administered Drugs Costing More Than $480/Day Projected Effect.
The Maze of Medicare Presented by: Larry Ulvila.
Thomas B. Valuck, MD, JD Medical Officer & Senior Adviser
Lauren Geyer Barnes Avalere Health LLC
University Benefits Brian Schlichting Gayle Schanou
The Heritage Version of The Health Insurance Exchange
Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Title III – Combating Waste, Fraud, and Abuse Janet Rehnquist, Esq. Venable.
The Role of the Private Sector in Part D
The Future of Biologics in Part D
Physician/ Clinical Services Other Personal Health Care
Jan Berger, M.D., M.J. Senior Vice President Chief Medical Officer
LEVERAGING PURCHASED/REFERRED CARE (PRC) RATES
Presentation transcript:

Competitive Acquisition Program Christian G. Downs, JD, MHA Executive Director Association of Community Cancer Centers

CAP No prescription drug coverage under the Medicare program Studies showed an overpayment for drugs MMA 2003 had several payment adjustments Overview Background Program Structure Beneficiaries Physician Participation Vendor Selection Conclusions

CAP Available to physicians who administer drugs in their office under Part B Acquire drugs from vendors rather than purchase Program is voluntary Overview Background Program Structure Beneficiaries Physician Participation Vendor Selection Conclusions

CAP A single national distribution area A single drug category for 181 drugs give “incident to” The physician/vendor enrollment process Overview Background Program Structure Beneficiaries Physician Participation Vendor Selection Conclusions

CAP No change in coverage No change in out of pocket cost CMS thinks that long term costs could decrease somewhat Overview Background Program Structure Beneficiaries Physician Participation Vendor Selection Conclusions

CAP Participation is voluntary Physician enrolls with vendor Vendor delivers drug Physician bills Medicare for professional and administrative services Vendor bills Medicare for drug Overview Background Program Structure Beneficiaries Physician Participation Vendor Selection Conclusions

CAP CMS has set out standards for vendors Vendor must then apply to Medicare program Vendor will be selected based on bid price Overview Background Program Structure Beneficiaries Physician Participation Vendor Selection Conclusions

CAP Not going into effect until July of 2006 Not popular with physicians as designed Not popular with vendors as designed Cost is issue attempting to be addressed Overview Background Program Structure Beneficiaries Physician Participation Vendor Selection Conclusions

REMEMBER "One of the penalties for refusing to participate in politics is that you end up being governed by your inferiors." -Plato Christian G. Downs, JD, MHA Executive Director Association of Community Cancer Centers (301) ext 220